Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Non-vascular Stents Market Size & Growth Forecast 2027–2036, By Segments (End Use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12536| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Non-vascular Stents Market size stood at USD 1.9 billion in 2026 and is predicted to grow at a 4.56% CAGR from 2027 to 2036, attaining USD 2.97 billion by 2036. The industry revenue for 2027 is estimated at USD 1.97 billion.

Base Year Value (2026)
USD 1.9 billion
CAGR (2027-2036)
4.56%
Forecast Year Value (2036)
USD 2.97 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Non-vascular Stents Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads due to high procedural volumes, mature hospital infrastructure, and strong clinical familiarity with minimally invasive stenting across gastrointestinal and urological applications.
  • Asia Pacific grows at 5.59% CAGR driven by expanding access to interventional care and rising adoption of minimally invasive procedures across high-volume clinical settings.

Segment Momentum

  • Hospitals lead the market because they manage complex stent procedures requiring multidisciplinary care, advanced imaging, and post-procedure monitoring, making them the primary setting for higher-acuity non-vascular stent interventions.
  • Esophageal Stents are growing fastest as demand increases for minimally invasive procedures that restore swallowing function and relieve obstruction through targeted, procedure-specific stent solutions.

Market Expansion Drivers

  • Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand.
  • Expanding clinical trials and surgical volumes supporting procedural adoption of stents.
  • Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care.

Leading Market Participants

  • Major players in the non-vascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), CONMED Corporation (United States), ELLA-CS, s.r.o. (Czech Republic), Glaukos Corporation (United States), Hobbs Medical, Inc. (United States), Merit Medical Systems, Inc. (United States).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 1.9 billion
  • 2027 Estimated Market Size: USD 1.97 billion.
  • Projected Market Size: USD 2.97 billion by 2036
  • Growth Forecast: 4.56% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End Use) | Gastrointestinal Stents (Type)
  • Emerging Opportunity Segment: Ambulatory Care Centers (ACS) (End Use) | Esophageal Stents (Type)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand

The expanding elderly population and increasing burden of chronic conditions are contributing to greater procedural requirements, which will support the non-vascular stents market across multiple therapeutic applications. Aging patients are more likely to experience gastrointestinal, biliary, respiratory, and other conditions that can cause narrowing or obstruction requiring mechanical support. Non-vascular stents can help maintain the openness of affected passages and facilitate minimally invasive management of these conditions. As healthcare systems increasingly focus on treating age-related and chronic disorders while reducing procedural burden, the availability of stenting options suited to different anatomical and clinical requirements is becoming increasingly important.

Expanding clinical trials and surgical volumes supporting procedural adoption of stents

Growing clinical research activity and increasing procedure volumes are strengthening the non-vascular stents market by generating broader clinical experience with stent-based interventions across different applications. Clinical trials can support the evaluation of new stent designs, materials, deployment methods, and therapeutic indications, while higher surgical volumes create greater opportunities for physicians to incorporate stenting into routine treatment pathways. Continued procedural experience can also improve familiarity among healthcare professionals and support the refinement of patient selection and placement techniques. The combination of clinical evidence development and expanding intervention volumes is increasing the role of stents in the management of non-vascular obstructions.

Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care

Technological progress in endoscopic intervention is opening additional opportunities for the non-vascular stents market by enabling physicians to manage certain conditions through less invasive procedures. Modern endoscopic techniques can provide direct access to affected anatomical areas while reducing the need for more invasive surgical approaches, making stent placement increasingly compatible with procedural settings outside traditional inpatient surgery. Improvements in visualization, delivery systems, and deployment techniques can also support more precise positioning and efficient intervention. As healthcare providers place greater emphasis on shorter recovery periods, procedural efficiency, and reduced hospitalization requirements, stent-based endoscopic treatments are becoming more relevant in outpatient and ambulatory care pathways.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand 2.00% High North America, Europe High Near Term
Expanding clinical trials and surgical volumes supporting procedural adoption of stents 1.80% High North America, Europe Medium Mid Term
Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care 1.50% High Asia Pacific, North America Emerging Long Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Non-vascular Stents Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

North America held the largest share of the non-vascular stents market in 2026, supported by advanced healthcare infrastructure, established interventional treatment capabilities, and broad access to specialized medical technologies. Growing demand for minimally invasive procedures is encouraging the use of stents across gastrointestinal, biliary, and other non-vascular applications. Strong clinical expertise, sophisticated hospital systems, and continued adoption of innovative interventional devices further support the region’s position, while increasing emphasis on less invasive treatment approaches is sustaining demand.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region in the non-vascular stents market, driven by expanding healthcare infrastructure, improving access to advanced medical procedures, and rising awareness of minimally invasive treatment options. Increasing healthcare expenditure and modernization of hospitals are creating broader opportunities for interventional devices. Growing patient demand for less invasive therapies, together with improvements in specialist care and diagnostic capabilities, is supporting greater adoption of non-vascular stents across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Clinical Applications

Germany’s non-vascular stents market reflects strong adoption of advanced medical solutions within specialized hospital environments. Providers focus on durable devices, procedural accuracy, and innovations that support complex interventions while maintaining high standards for patient care and device performance.

France 🇫🇷

Specialized Treatment Solutions

France’s non-vascular stents market centers on advanced clinical applications requiring effective and reliable implantable devices. Healthcare providers prioritize solutions that support minimally invasive procedures, enhance therapeutic outcomes, and integrate with specialized care pathways across hospitals and clinics.

Italy 🇮🇹

Hospital Procedure Support

Italy’s non-vascular stents market is driven by healthcare demand for dependable devices used in complex therapeutic procedures. Hospitals focus on solutions that improve intervention quality, simplify clinical workflows, and provide effective support for gastrointestinal and airway-related treatments.

Japan 🇯🇵

Aging Care Technologies

Japan’s non-vascular stents market is influenced by increasing demand for minimally invasive treatment approaches in digestive and respiratory care. Medical institutions emphasize dependable devices that support complex procedures, improve patient comfort, and align with evolving healthcare needs.

South Korea 🇰🇷

Procedure Innovation Focus

South Korea’s non-vascular stents market is shaped by expanding adoption of advanced endoscopic and interventional procedures. Hospitals seek innovative stent technologies that improve treatment flexibility, support physician efficiency, and address growing demand for specialized medical interventions.

United States 🇺🇸

Advanced Medical Devices

The U.S. non-vascular stents market is supported by demand for minimally invasive interventions across gastrointestinal, airway, and urological procedures. Healthcare providers prioritize reliable stent designs, improved patient outcomes, and technologies that enhance procedural efficiency in specialized clinical settings.

Segment Analysis

Segment Leadership and Growth Trends

Non-vascular Stents Market Share (%), by End Use, 2026

Hospitals
Ambulatory Care Centers (ACS)
Specialty Clinics

Go beyond the chart, access full insights & data tables

Request Free Sample Report

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Care Centers (ACS) (Fastest-Growing Segment)

Hospitals held the largest share of the non-vascular stents market in 2026, supported by their role in managing complex gastrointestinal, airway, and other non-vascular conditions requiring specialized interventional procedures. Hospitals provide access to advanced diagnostic infrastructure, multidisciplinary clinical teams, and procedural facilities needed for stent placement and patient monitoring. The concentration of specialized care within hospital settings continues to support their position, particularly for patients requiring complex interventions or comprehensive post-procedure management.

Ambulatory care centers (ACS) are gaining adoption as healthcare systems increasingly emphasize convenient, efficient, and less resource-intensive procedural care. Advances in minimally invasive techniques and improvements in patient selection can enable selected non-vascular stent procedures to be performed outside traditional inpatient environments. Greater focus on reducing hospital resource utilization, improving patient convenience, and expanding outpatient treatment capacity is supporting the increasing role of ambulatory care settings.

Type Segment Analysis: Gastrointestinal Stents (Largest Segment) vs Esophageal Stents (Fastest-Growing Segment)

The gastrointestinal stents segment represented the largest share of the non-vascular stents market in 2026. Its leading position is supported by the broad clinical need to restore or maintain gastrointestinal passage in patients experiencing obstructions and other conditions affecting digestive tract function. Stents provide a minimally invasive option for improving luminal patency and supporting symptom management, making them an important component of interventional gastrointestinal care. Increasing adoption of minimally invasive procedures and improvements in stent design continue to support demand for gastrointestinal stenting solutions.

Esophageal stents are expanding as clinicians increasingly use minimally invasive approaches to manage esophageal obstruction and related complications. Improvements in stent design, deployment techniques, and patient management are helping support more effective treatment while reducing the need for more invasive interventions in appropriate cases. Growing emphasis on rapid symptom relief, improved swallowing function, and less invasive treatment pathways is contributing to greater adoption of esophageal stenting within specialized care settings.

Segment Sub-Segment Largest Segment Fastest Growing
End Use Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics Hospitals Ambulatory Care Centers (ACS)
Type Gastrointestinal Stents, Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents, Pulmonary (Airway) Stents, Silicone Airway, Metallic Airway, Urological Stents, Others Gastrointestinal Stents Esophageal Stents
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the non-vascular stents market:

1. Medtronic plc (Ireland)

2. Boston Scientific Corporation (United States)

3. Becton Dickinson and Company (United States)

4. Cook Medical LLC (United States)

5. CONMED Corporation (United States)

6. ELLA-CS s.r.o. (Czech Republic)

7. Glaukos Corporation (United States)

8. Hobbs Medical Inc. (United States)

9. Merit Medical Systems Inc. (United States)

The non-vascular stents market is advancing through innovations in minimally invasive device design and material engineering. Frequent introduction of improved stent solutions is enhancing procedural outcomes and patient recovery. Collaborative efforts with healthcare systems are supporting broader adoption of advanced stent technologies.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Medtronic plc (Ireland)
Boston Scientific Corporation (United States)
Becton Dickinson and Company (United States)
Cook Medical LLC (United States)
CONMED Corporation (United States)
ELLA-CS s.r.o. (Czech Republic)
Glaukos Corporation (United States)
Hobbs Medical Inc. (United States)
Merit Medical Systems Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Cook Medical Mar-24 Cook Medical and Getinge signed a commercial distribution agreement for the iCast covered stent system in the United States. The collaboration aims to expand patient access to the device across relevant clinical settings for vascular and endovascular treatment applications.
BD (Becton, Dickinson and Company) Mar-24 BD initiated first patient enrollment in its AGILITY investigational device exemption study evaluating the BD Vascular Covered Stent for peripheral arterial disease treatment. The study assesses safety and effectiveness to support clinical validation and potential regulatory advancement.
Becton, Dickinson and Company Mar-24 Becton, Dickinson and Company initiated first patient enrollment in the AGILITY investigational device exemption study in March 2024. The clinical trial evaluates the BD Vascular Covered Stent for treatment of peripheral arterial disease, supporting regulatory validation and clinical evidence generation for next-generation endovascular stent technologies.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Non-vascular Stents Market — Custom Segments

Segment Sub-Segment
Stent Material Metal Stents, Silicone Stents, Polymer Stents, Biodegradable Stents
Placement Duration Temporary Stents, Short-Term Stents, Long-Term Stents, Permanent Stents
Procedure Type Endoscopic Stenting, Bronchoscopic Stenting, Ureteroscopic Stenting, Percutaneous Stenting

Non-vascular Stents Market — Custom TOC

Custom Chapter Custom Details
Clinical Adoption Barrier Assessment
  • Physician Adoption Drivers Across Non-Vascular Stent Applications
  • Clinical Evidence and Procedure Selection Considerations
  • Device Performance, Safety, and Usability Requirements
  • Hospital and Clinician Barriers to Technology Adoption
  • Opportunities to Accelerate Clinical Uptake
Emerging Application Opportunity Mapping
  • Non-Vascular Stent Applications Across Gastrointestinal and Other Anatomical Sites
  • Unmet Clinical Needs Driving Application Expansion
  • Procedure-Specific Device Requirements
  • Emerging Patient and Procedure Opportunities
  • Application Areas With Commercial Expansion Potential
Reimbursement and Healthcare Economics Analysis
  • Reimbursement Structures Across Key Procedure Settings
  • Hospital Economics and Procedure Cost Considerations
  • Coverage Policies and Access Constraints
  • Economic Value Drivers for Stent Adoption
  • Strategies Supporting Broader Healthcare System Adoption

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current revenue of the non-vascular stents market?

The market size of the non-vascular stents is estimated at USD 1.97 billion in 2027.

How is the non-vascular stents industry size expected to evolve during the forecast period?

Non-vascular Stents Market size stood at USD 1.9 billion in 2026 and is predicted to grow at a 4.56% CAGR from 2027 to 2036, attaining USD 2.97 billion by 2036.

How are demographic and chronic disease trends influencing demand in the non-vascular stents market?

Aging populations and increasing chronic conditions are expanding demand for stents that relieve obstructions through less invasive treatment. Longer-term disease management also supports repeat procedures, greater physician familiarity, and routine adoption across gastroenterology and urology.

How are minimally invasive procedures reshaping stent adoption in the non-vascular stents market?

Advances in endoscopic visualization and delivery systems are making stent placement more suitable for outpatient settings. Providers increasingly favor stents that integrate with efficient endoscopic workflows, improving procedural accessibility and reducing reliance on inpatient surgical care.

Why do hospitals lead the non-vascular stents market?

Hospitals lead the market because they manage complex stent procedures requiring multidisciplinary care, advanced imaging, and post-procedure monitoring, making them the primary setting for higher-acuity non-vascular stent interventions.

Why are Esophageal Stents the fastest-growing type segment?

Esophageal Stents are growing fastest as demand increases for minimally invasive procedures that restore swallowing function and relieve obstruction through targeted, procedure-specific stent solutions.

Why does North America lead the non-vascular stents market?

North America leads due to high procedural volumes, mature hospital infrastructure, and strong clinical familiarity with minimally invasive stenting across gastrointestinal and urological applications.

What is driving growth in the Asia Pacific non-vascular stents market?

Asia Pacific grows at 5.59% CAGR driven by expanding access to interventional care and rising adoption of minimally invasive procedures across high-volume clinical settings.

Which companies are driving growth in the non-vascular stents landscape?

Major players in the non-vascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), CONMED Corporation (United States), ELLA-CS, s.r.o. (Czech Republic), Glaukos Corporation (United States), Hobbs Medical, Inc. (United States), Merit Medical Systems, Inc. (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →